)
Visual
test
Bactiguard
Bactiguard (BACTI) investor relations material
Bactiguard Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary5 Feb, 2026
Executive summary
Q4 delivered strong results with EBITDA of SEK 25 million, driven by an updated Zimmer Biomet agreement and cost discipline; full-year EBITDA reached SEK 44 million despite lower total revenues due to currency effects and discontinued business.
Strategic transformation continued, focusing on licensed partnerships, wound management, and expansion into cardiology and neurology, with investments in regulatory and digital capabilities.
Partnerships with BD and Zimmer Biomet were strengthened, supporting growth and market penetration.
Focused on higher profitability products and enhanced R&D and regulatory expertise.
Financial highlights
Q4 total revenue was SEK 65.6 million; full-year revenue was SEK 228.8 million, with Q4 net sales up 10% net of currency effects.
Q4 EBITDA was SEK 24.7 million (up from 8.4 million YoY); full-year EBITDA was SEK 43.8 million (up from 18.0 million YoY).
Q4 net profit was SEK 12.5 million; full-year net loss was SEK 7.8 million, an improvement from SEK 29.8 million loss YoY.
Operating costs for the year decreased by over 25% to SEK 154 million, aided by a SEK 7 million reduction in provisions from the Zimmer agreement.
Cash at year-end was SEK 44 million; positive Q4 cash flow, but full-year cash flow was negative due to SEK 51 million voluntary loan repayment.
Outlook and guidance
Strategic targets for 2030 reiterated: at least SEK 600 million in revenue and SEK 200 million EBITDA, with more than 10 application areas in exclusivity or licensed partnership phases.
Expectation of double-digit growth in wound management, led by Hydrocyn, and positive contributions from sutures going forward.
Growth anticipated from BD as new markets (India, Europe) ramp up, with additional launches expected in 2026.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebJ
Strong growth, digital innovation, and margin expansion drive robust multi-year financial outlook. - 6 Feb004020
Operating profit rose on cost savings and high-value sales, with major US expansion underway. - 6 FebJOUT
Net sales up 31%, gross margin at 36.6%, and net loss narrowed to $3.3 million. - 6 FebPECO
Record 2025 occupancy and 7% Core FFO growth; 2026 targets 5.5% FFO growth and strong acquisitions. - 6 FebPROV
Q2 FY2026 net income rose 65% year-over-year, with higher margins and strong credit quality. - 6 FebNVDA
AI-driven digital twins and accelerated computing are set to revolutionize industrial design and manufacturing. - 6 FebCDP
2025 FFO/share rose 5.8% to $2.72, with strong leasing and investment; 2026 guidance signals more growth. - 6 FebCRI
Q1 2025 saw record revenue, a return to profit, and major new contracts in space technology. - 6 FebCRINet loss widened to 7.5m PLN in H1 2024 as revenue fell and R&D costs remained high.
- 6 FebCRINet loss deepened on lower sales and higher costs, but major new contracts and restructuring are underway.
Next Bactiguard earnings date
Q1 202623 Apr, 2026
Bactiguard
Next Bactiguard earnings date
Q1 202623 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Bactiguard Holding AB, a medical device company, engages in the development and supply of infection prevention solutions in Sweden and internationally. The company offers PrimoVac, which is an antimicrobial wound dressing to fight infection following post-surgical procedures or other surgeries that disturb the body's natural barrier against infection. It operates through two segments: Healthcare and Other. Its Healthcare segment offers PrimoVac, as well as disinfectants for infusion systems used in healthcare facilities; burn health care products for treatment of burns, minor wounds for everyday use and products for infrequent use; plastic surgery materials; products used to aid wound healing; rinsing irrigation systems for surgical procedures; adhesives for orthopedic surgery; non-adherent dressings under the BactiDrain™ brand are used to collect fluid from wounds by vacuum action; surgical bags and drainage trolleys that are designed to keep drains organized during surgery; and hand hygiene products containing natural essential oils among others. Bactiguard Holding is based in Tullinge, Sweden.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage